Top 10 FDA 483 Observations in 2026 (and How to Avoid Each One)

Every year, FDA investigators write thousands of 483 observations — and almost every one was avoidable. Marcus and Priya count down the ten most-cited observations in drug manufacturing for 2026, what investigators are actually finding, and exactly how to keep your site off the list. • The #1 most-cited observation — and why it explains the other nine • Data integrity: the fastest-growing citation cluster in 2026 • Why "human error + retraining" keeps failing investigations • The one quality-unit decision that changes everything New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one. Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161 Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.